(S)-(1-hexyl-5-hydroxy-4-oxo-1,4-dihydropyridin-2-yl)methyl 2-amino-3-phenylpropanoate

ID: ALA4556868

PubChem CID: 72163243

Max Phase: Preclinical

Molecular Formula: C21H28N2O4

Molecular Weight: 372.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCCCn1cc(O)c(=O)cc1COC(=O)[C@@H](N)Cc1ccccc1

Standard InChI:  InChI=1S/C21H28N2O4/c1-2-3-4-8-11-23-14-20(25)19(24)13-17(23)15-27-21(26)18(22)12-16-9-6-5-7-10-16/h5-7,9-10,13-14,18,25H,2-4,8,11-12,15,22H2,1H3/t18-/m0/s1

Standard InChI Key:  YYFGOTXRWISRGI-SFHVURJKSA-N

Molfile:  

 
     RDKit          2D

 27 28  0  0  0  0  0  0  0  0999 V2000
   20.8287  -19.9138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8276  -20.7334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5356  -21.1423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2453  -20.7329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2424  -19.9102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5338  -19.5050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9536  -21.1404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9549  -21.9576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6632  -22.3651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2478  -22.3673    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6645  -23.1823    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.3703  -21.9554    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.0787  -22.3628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7857  -21.9531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4919  -22.3654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1969  -21.9591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1998  -21.1416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4916  -20.7319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7805  -21.1398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9084  -20.7346    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.4931  -19.9147    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.4896  -23.1825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1962  -23.5931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9051  -23.1865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6116  -23.5971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3205  -23.1904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0270  -23.6010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  1
  9 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 19  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 18 21  2  0
 15 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
M  END

Associated Targets(Human)

TYR Tclin Tyrosinase (717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.47Molecular Weight (Monoisotopic): 372.2049AlogP: 2.75#Rotatable Bonds: 10
Polar Surface Area: 94.55Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.76CX Basic pKa: 6.77CX LogP: 3.52CX LogD: 3.43
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.49Np Likeness Score: 0.07

References

1. Pillaiyar T, Namasivayam V, Manickam M, Jung SH..  (2018)  Inhibitors of Melanogenesis: An Updated Review.,  61  (17): [PMID:29763564] [10.1021/acs.jmedchem.7b00967]

Source